Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications
- 15 December 2020
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 40 (9) , 1555-1569
Abstract
Colorectal cancer (CRC) is a major cause of cancer mortality worldwide, however, the molecular mechanisms underlying the pathogenesis of CRC remain largely unclear. Recent studies have revealed crucial roles of transcription factors in CRC development. Transcription factors essential for the regulation of gene expression by interacting with transcription corepressor/enhancer complexes and they orchestrate downstream signal transduction. Deregulation of transcription factors is a frequent occurrence in CRC, and the accompanying drastic changes in gene expression profiles play fundamental roles in multistep process of tumorigenesis, from cellular transformation, disease progression to metastatic disease. Herein, we summarized current and emerging key transcription factors that participate in CRC tumorigenesis, and highlighted their oncogenic or tumor suppressive functions. Moreover, we presented critical transcription factors of CRC, emphasized the major molecular mechanisms underlying their effect on signal cascades associated with tumorigenesis, and summarized of their potential as molecular biomarkers for CRC prognosis therapeutic response, as well as drug targets for CRC treatment. A better understanding of transcription factors involved in the development of CRC will provide new insights into the pathological mechanisms and reveal novel prognostic biomarkers and therapeutic strategies for CRC.Keywords
Funding Information
- National Natural Science Foundation of China (81772501, 81802331)
- Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (06170686)
- Research Grants Council, University Grants Committee (14101917, 14108718, 14163817, 14110819)
This publication has 167 references indexed in Scilit:
- The Myb-p300-CREB axis modulates intestine homeostasis, radiosensitivity and tumorigenesisCell Death & Disease, 2013
- Knockdown of c‐Fos suppresses the growth of human colon carcinoma cells in athymic miceInternational Journal of Cancer, 2011
- Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer TherapyThe American Journal of Pathology, 2011
- NF-κB and cancer: how intimate is this relationshipMolecular and Cellular Biochemistry, 2009
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated CancerCancer Cell, 2009
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradationNature Cell Biology, 2008
- Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironmentNature Reviews Immunology, 2007
- Colorectal cancer: genetics of development and metastasisJournal of Gastroenterology, 2006
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- Transcriptional regulation by the phosphorylation-dependent factor CREBNature Reviews Molecular Cell Biology, 2001